2,005
Views
2
CrossRef citations to date
0
Altmetric
Education and Management

Non-adherence and sub-optimal treatment with asthma medications in young adults: a population-based cohort study

, PhDORCID Icon, , PhD, , PhDORCID Icon, , PhD, , PhD & , PhDORCID Icon
Pages 1661-1669 | Received 08 Mar 2021, Accepted 04 Jun 2021, Published online: 13 Aug 2021

References

  • Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2020 [accessed 2020 Jun]. https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf
  • Reddel HK, Busse WW, Pedersen S, Tan WC, Chen YZ, Jorup C, Lythgoe D, O’Byrne PM. Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study. Lancet. 2017;389(10065):157–166.
  • Reddel HK, Ampon RD, Sawyer SM, Peters MJ. Risks associated with managing asthma without a preventer: urgent healthcare, poor asthma control and over-the-counter reliever use in a cross-sectional population survey. BMJ Open. 2017;7(9):e016688.
  • O’Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK. Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med. 2018;378(20):1865–1876.
  • Bateman ED, Reddel HK, O’Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Engl J Med. 2018;378(20):1877–1887.
  • Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short-acting β. Eur Respir J. 2020;55(4):1901872.
  • Murphy J, McSharry J, Hynes L, Matthews S, Van Rhoon L, Molloy GJ. Prevalence and predictors of adherence to inhaled corticosteroids in young adults (15-30 years) with asthma: a systematic review and meta-analysis. J Asthma. 2020;58(5):683–705.
  • Desai M, Oppenheimer JJ. Medication adherence in the asthmatic child and adolescent. Curr Allergy Asthma Rep. 2011;11(6):454–464.
  • World Health Organization. Adherence to long-term therapies: evidens for action. Geneva (Switzerland): WGO; 2003 [accessed 2020 Jun]. https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf.
  • Peláez S, Lamontagne AJ, Collin J, Gauthier A, Grad RM, Blais L, Lavoie KL, Bacon SL, Ernst P, Guay H, et al. Patients’ perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy. BMC Pulm Med. 2015;15:42.
  • Dahlén E, Komen J, Jonsson EW, Almqvist C, Kull I, Wettermark B. Eliminated patient fee and changes in dispensing patterns of asthma medication in ­children—an interrupted time series analysis. Basic Clin Pharmacol Toxicol. 2019;125(4):360–369.
  • Øymar K, Mikalsen IB, Furu K, Nystad W, Karlstad Ø. Prescription patterns of inhaled corticosteroids for preschool children—a Norwegian register study. Pediatr Allergy Immunol. 2015;26(7):655–661.
  • Roberts G, Vazquez-Ortiz M, Knibb R, Khaleva E, Alviani C, Angier E, Blumchen K, Comberiati P, Duca B, DunnGalvin A, et al. EAACI guideline on the effective transition of adolescents and young adults with allergy and asthma. Allergy. 2020;75(11):2734–2752.
  • Ödling M, Andersson N, Hallberg J, Almqvist C, Janson C, Bergström A, Melén E, Kull I. A gap between asthma guidelines and management for adolescents and young adults. J Allergy Clin Immunol Pract. 2020;8(9):3056–3065.e2.
  • Wang L, Palmer AJ, Otahal P, Cocker F, Sanderson K. Multimorbidity and health care service utilization in the Australian workforce: findings from the National Health Survey. J Occup Environ Med. 2017;59(8):795–802.
  • Wickman M, Kull I, Pershagen G, Nordvall SL. The BAMSE project: presentation of a prospective longitudinal birth cohort study. Pediatr Allergy Immunol. 2002;13(s15):11–13.
  • Melén E, Bergström A, Kull I, Almqvist C, Andersson N, Asarnoj A, Borres MP, Georgellis A, Pershagen G, Westman M, et al. Male sex is strongly associated with IgE-sensitization to airborne but not food allergens: results up to age 24 years from the BAMSE birth cohort. Clin Transl Allergy. 2020;10:15.
  • Wang G, Hallberg J, Um Bergström P, Janson C, Pershagen G, Gruzieva O, van Hage M, Georgelis A, Bergström A, Kull I, et al. Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE. Eur Respir J. 2020;57(3):2002120.
  • Wettermark B, Hammar N, Fored CM, MichaelFored C, Leimanis A, Olausson PO, Persson I, Sundström A, Westerholm B, Rosén M. The new Swedish Prescribed Drug Register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735.
  • Wallerstedt SM, Wettermark B, Hoffmann M. The first decade with the Swedish Prescribed Drug Register—a systematic review of the output in the scientific literature. Basic Clin Pharmacol Toxicol. 2016;119(5):464–469.
  • Eriksson I, Cars T, Piehl F, Malmström RE, Wettermark B, von Euler M. Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study. Eur J Clin Pharmacol. 2018;74(2):219–226.
  • Forslund T, Wettermark B, Hjemdahl P. Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation. Eur J Clin Pharmacol. 2016;72(3):329–338.
  • Zarrinkoub R, Wettermark B, Wändell P, Mejhert M, Szulkin R, Ljunggren G, Kahan T. The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail. 2013;15(9):995–1002.
  • Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47.
  • Dahlén E, Ekberg S, Lundholm C, Jonsson EW, Kull I, Wettermark B, Almqvist C. Sibship and dispensing patterns of asthma medication in young children-a population-based study. Pharmacoepidemiol Drug Saf. 2019;28(8):1109–1116.
  • WHO Collaborating Center for Drug Statistics Methodology, Oslo. Guidelines for ATC classification and DDD assignment; 2021 [accessed 2021 Jan]. https://www.whocc.no/filearchive/publications/2021_guidelines_web.pdf
  • Shlomi D, Katz I, Segel MJ, Oberman B, Peled N. Determination of asthma control using administrative data regarding short-acting beta-agonist inhaler purchase. J Asthma. 2018;55(5):571–577.
  • O’Byrne PM, Reddel HK, Beasley R. The management of mild asthma. Eur Respir J. 2020:2003051.
  • Kaye L, Theye B, Smeenk I, Gondalia R, Barrett MA, Stempel DA. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020;8(7):2384–2385.
  • Ödling M, Jonsson M, Janson C, Melén E, Bergström A, Kull I. Lost in the transition from pediatric to adult healthcare? Experiences of young adults with severe asthma. J Asthma. 2019;57(10):1119–1127.
  • Örtqvist AK, Lundholm C, Wettermark B, Ludvigsson JF, Ye W, Almqvist C. Validation of asthma and eczema in population-based Swedish drug and patient registers. Pharmacoepidemiol Drug Saf. 2013;22(8):850–860.
  • Vrijens B, Dima AL, Van Ganse E, van Boven JF, Eakin MN, Foster JM, de Bruin M, Chisholm A, Price D. What we mean when we talk about adherence in respiratory medicine. J Allergy Clin Immunol Pract. 2016;4(5):802–812.